These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 957902)

  • 21. Block of cerebral actions of L-dopa with methyl receptor substances.
    Cotzias GC; Tang L; Ginos JZ; Nicholson AR; Papavasiliou PS
    Nature; 1971 Jun; 231(5304):533-5. PubMed ID: 4934569
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of carbidopa on the metabolism of L-dopa in the pigtail monkey.
    Bronaugh RL; Wenger GR; Garver DL; Rutledge CO
    Biochem Pharmacol; 1976 Jul; 25(14):1679-81. PubMed ID: 821489
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
    Rose S; Jenner P; Marsden CD
    Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of tetrahydropapaveroline with inhibition of dopa-decarboxylase by Ro 4-4602 in brain: effects on alcohol drinking in the rat.
    Miñano FJ; McMillen BA; Myers RD
    Alcohol; 1989; 6(2):133-7. PubMed ID: 2713086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the dopa decarboxylase inhibitor MK-486 on L-dopa-induced inhibition of prolactin secretion: evidence for CNS participation in the L-dopa effects.
    Szabo M; Nakawatase C; Kovathana N; Frohman LA
    Neuroendocrinology; 1977; 24(1):24-34. PubMed ID: 600362
    [No Abstract]   [Full Text] [Related]  

  • 26. Central decarboxylation and uptake of L-DOPA.
    Andén NE; Engel J; Rubenson A
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):11-26. PubMed ID: 4260798
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease.
    Rappelli A; Glorioso N; Tedde R; Dessi'-Fulgheri P; Monaco F
    J Neurol Neurosurg Psychiatry; 1978 Oct; 41(10):915-8. PubMed ID: 731241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
    Weiss BF; Roel LE; Munro HN; Wurtman RJ
    Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of L-dopa and alpha-methyldopa on reflexes and sympathetic nerve function.
    Antonaccio MJ; Robson RD; Burrell R
    Eur J Pharmacol; 1974 Jan; 25(1):9-18. PubMed ID: 4435015
    [No Abstract]   [Full Text] [Related]  

  • 30. Ethanol, levodopa and inhibitors of extracerebral aromatic L-amino acid decarboxylase: a drug-drug interaction study.
    Messiha FS
    Proc West Pharmacol Soc; 1977; 20():327-31. PubMed ID: 896840
    [No Abstract]   [Full Text] [Related]  

  • 31. The metabolism of exogenous L-dopa in the brain: an immunohistochemical study of its conversion to dopamine in non-catecholaminergic cells of the rat brain.
    Tison F; Mons N; Geffard M; Henry P
    J Neural Transm Park Dis Dement Sect; 1991; 3(1):27-39. PubMed ID: 2064729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normalization of brain serotonin by L-tryptophan in levodopa-treated rats.
    Fahn S; Snider S; Prasad AL; Lane E; Makadon H
    Neurology; 1975 Sep; 25(9):861-5. PubMed ID: 1172210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protriptyline induced inhibition of the in vivo 3H-noradrenaline synthesis from 3H-L-dopa in the rat brain.
    Nielsen M; Eplov L; Scheel-Krüger J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):15-28. PubMed ID: 4280017
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D; Buser P
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract]   [Full Text] [Related]  

  • 35. On the mechanism of L-dopa-induced postural hypotension in the cat.
    Dhasmana KM; Spilker BA
    Br J Pharmacol; 1973 Mar; 47(3):437-51. PubMed ID: 4147189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of L-dopa with and without inhibition of extra cerebral dopa decarboxylase on gastric acid secretion and gastrin release in man.
    Caldara R; Barbieri C; Piepoli V; Borzio M; Masci E
    Gut; 1985 Oct; 26(10):1014-7. PubMed ID: 4054700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide.
    Miñano FJ; Myers RD
    Psychopharmacology (Berl); 1989; 98(2):176-82. PubMed ID: 2502790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of L-DOPA analogues in Sidman avoidance performance in mice.
    Thut PD
    Life Sci; 1977 Aug; 21(3):423-31. PubMed ID: 895374
    [No Abstract]   [Full Text] [Related]  

  • 39. The action of L-dopa in rats with the raphe nuclei lesions.
    Maj J; Przewlocka B
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):151-4. PubMed ID: 1208224
    [No Abstract]   [Full Text] [Related]  

  • 40. Carbidopa attenuation of L-DOPA emesis in dogs: evidence for a cerebral site of action outside the blood-brain barrier.
    Lotti VJ; Clark C
    Eur J Pharmacol; 1974 Mar; 25(3):322-5. PubMed ID: 4827858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.